Advances in immunotherapy have ushered in a new era of treatment for follicular lymphoma (FL), particularly for patients who have experienced relapse ...

The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...

Breast health campaigner Joanna Newark, 52, is encouraging everyone to incorporate a daily breast self-exam into their ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Chemotherapy targets cancer cells by disrupting DNA replication and mitotic processes, despite side effects on healthy cells.

Jaguar Health (JAGX) announced that it is seeking a partner to fund and execute the development and commercialization of NP300, the company’s ...

GlobeNewswire, Health, Pharmaceuticals & Biotechnology, Product / Services Announcement | Ziihera is the first and only dual HER2-targeted bispecific ...

Annual BioTech Breakthrough Award is devoted to honoring excellence in life science and biotechnology solutions, services, ...

(“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of a novel oncology therapeutic intended to improve the outcomes and quality of life for patients, ...

But there is a lot behind this term in the challenge to tumors. In the future and beyond. CAR-T stands for Chimeric Antigens ...

In this way, they indeed found that tumor inhibitors with the same mechanisms of action produce similar metabolite profiles ...